For men in Canada considering testosterone replacement therapy (TRT), one of the most common concerns is heart health.
You've probably heard the warnings—claims that TRT could increase the risk of heart attacks, strokes, or blood clots. It's a topic that has caused hesitation for many men over 40 who might otherwise benefit from treatment.
The truth? The relationship between testosterone and cardiovascular risk is far more nuanced than the headlines suggest. Recent studies have shown that when low testosterone is properly diagnosed, and TRT is medically supervised, the therapy is not only safe for the heart—it may even improve key risk factors like cholesterol, inflammation, and insulin resistance.
This article unpacks the myths, the latest science, and how testosterone replacement therapy in Canada can support both hormonal health and cardiovascular well-being.
Topics covered in this article:
In the early 2010s, the testosterone-heart health debate kicked off with alarming headlines and some flawed studies that placed TRT under harsh scrutiny. The U.S. Food and Drug Administration (FDA) issued a safety communication in 2015 warning that testosterone products may carry an increased risk of heart attack and stroke, prompting changes to product labels to reflect these possible risks—even though some underlying data were inconclusive or poorly analyzed.
Much of the concern stemmed from studies like Vigen et al. (2013) and Finkle et al. (2014). In these studies, TRT appeared linked to higher cardiovascular events, but further scrutiny revealed serious methodological issues—such as missing control groups, skewed data, or errors in how events were counted.
Media amplification of these results fueled widespread anxiety, even as the scientific community began to question the validity of those conclusions.
Today, leading medical reviews—including those published in the Mayo Clinic Proceedings and stated by the Androgen Society—point out that these older studies are not reliable indicators of real-world heart risk from TRT, especially when correctly prescribed in men with clinically low testosterone.
Recent, high‑quality studies overwhelmingly support the conclusion that properly prescribed testosterone replacement therapy (TRT) does not increase cardiovascular risk—and may even offer benefits for heart health in men over 40.
A 2024 meta‑analysis by Corona et al., which reviewed over 8,000 men across randomized controlled trials, reported no significant difference between TRT and placebo in major cardiovascular events—even when considering atrial fibrillation risk. Similarly, a large updated meta‑analysis published in the Journal of the American College of Cardiology found no increase in cardiovascular risk or mortality in hypogonadal men receiving TRT.
The landmark TRAVERSE trial—a randomized study of more than 5,200 men (ages 45–80) with hypogonadism and cardiovascular risk factors—found TRT was non-inferior to placebo regarding heart attack, stroke, or cardiovascular death over a mean of 27 months of follow-up. A recent review of the TRAVERSE data similarly affirmed its cardiovascular safety stance.
In Canada, the Canadian Urological Association guidelines emphasize that men with low testosterone are at an increased risk of heart disease if left untreated, and they affirm that individualized treatment under medical supervision remains an acceptable option for most men—even those with stable cardiovascular conditions. Health Canada also continues to require cardiovascular risk assessment and ongoing monitoring, but does not ban TRT, recognizing that properly managed therapy is generally safe.
Altogether, the latest evidence offers reassurance: when testosterone replacement therapy is used correctly, it does not harm—and may even support—heart health in men over 40.
Balanced testosterone levels play a surprisingly important role in supporting cardiovascular health—especially in men over 40. While past concerns focused on the risks of testosterone therapy, more recent research highlights how healthy testosterone can benefit heart function through several key mechanisms.
Here's how optimized testosterone supports heart health:
When testosterone levels are too low, men are more likely to develop risk factors like abdominal fat, elevated triglycerides, and high blood pressure—all of which put extra strain on the heart. For many men in Canada, testosterone replacement therapy (TRT) can help restore hormonal balance and offer protective effects when guided by a qualified healthcare provider.
While testosterone replacement therapy (TRT) is generally safe for most men when medically supervised, it's not appropriate for everyone. Understanding who should proceed with caution—and who likely has little to worry about—is key to using TRT responsibly.
Men who should be more cautious with TRT include:
However, for most men over 40 with stable cardiovascular conditions, mild hypertension, or controlled type 2 diabetes, recent evidence suggests TRT does not increase heart attack or stroke risk—and may even improve risk factors when used correctly.
In Canada, clinicians typically assess cardiovascular and prostate health before starting therapy, then monitor regularly to keep treatment within a safe, therapeutic range. The key takeaway? TRT isn't off-limits for men with common age-related concerns—it just needs to be approached with the right context and care.
In Canada, testosterone replacement therapy (TRT) is regulated and medically supervised to ensure safety—especially when it comes to cardiovascular health. Reputable clinics follow evidence-based protocols that prioritize ongoing monitoring and individualized treatment.
Here's what responsible TRT care looks like in Canada:
This type of structured, proactive care gives men over 40 in Canada confidence that they can pursue TRT without compromising heart health. When managed responsibly, TRT becomes a tool for restoring energy and vitality—not a cardiovascular gamble.
Testosterone replacement therapy (TRT) can be part of a heart-healthy life—when it's combined with smart habits, proper screening, and consistent medical follow-up. For men over 40 in Canada, the goal isn't just boosting testosterone—it's optimizing overall health while minimizing risks.
Here's how to do it safely and effectively:
Balancing testosterone and heart health isn't about choosing one over the other. With proper screening and lifestyle support, TRT can be part of a strong, heart-smart plan for aging well.
For years, men over 40 have been told to be cautious—even fearful—about testosterone replacement therapy (TRT) and its effects on the heart. But today's research tells a different story. When low testosterone is properly diagnosed and treatment is medically supervised, TRT does not increase cardiovascular risk—and may actually help by improving key factors like cholesterol, blood sugar, and inflammation.
In Canada, responsible TRT programs include full screenings, ongoing monitoring, and personalized care. That means you can restore energy, motivation, and quality of life without putting your heart at risk. You don't have to choose between feeling better and staying safe. With the right guidance, you can have both.
Yes—recent studies, including the large TRAVERSE trial, show that testosterone replacement therapy (TRT) does not increase the risk of heart attack or stroke when used appropriately. In fact, TRT may improve cardiovascular markers like cholesterol and insulin sensitivity in men with low testosterone.
Early studies around 2013 raised concerns, but they had major flaws and were later challenged. The media amplified these warnings, leading to confusion. Today's more rigorous research shows that TRT is safe for most men when properly monitored.
Possibly, yes. If your condition is stable and you're being monitored by a doctor, TRT may still be a safe option. In Canada, many clinics work in coordination with your primary care provider or cardiologist to ensure it's done safely.
Doctors will typically check testosterone levels, cholesterol, PSA, hematocrit, blood pressure, and possibly inflammation markers before starting TRT. Ongoing blood work every 3 to 6 months helps monitor for any risks or necessary dose adjustments.
It might. TRT can improve lean muscle mass, reduce abdominal fat, enhance insulin sensitivity, and improve cholesterol profiles—all of which are linked to better heart health when managed properly.